SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001385508-23-000045
Filing Date
2023-02-27
Accepted
2023-02-27 16:04:08
Documents
13
Period of Report
2023-02-23
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 8-K opnt-20230223.htm   iXBRL 8-K 55462
  Complete submission text file 0001385508-23-000045.txt   237605

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT opnt-20230223.xsd EX-101.SCH 2150
3 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT opnt-20230223_def.xml EX-101.DEF 15433
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT opnt-20230223_lab.xml EX-101.LAB 29833
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT opnt-20230223_pre.xml EX-101.PRE 16094
7 EXTRACTED XBRL INSTANCE DOCUMENT opnt-20230223_htm.xml XML 14553
Mailing Address 233 WILSHIRE BLVD SUITE 400 SANTA MONICA CA 90401
Business Address 233 WILSHIRE BLVD SUITE 400 SANTA MONICA CA 90401 (310) 598-5410
OPIANT PHARMACEUTICALS, INC. (Filer) CIK: 0001385508 (see all company filings)

IRS No.: 464744124 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38193 | Film No.: 23674699
SIC: 2834 Pharmaceutical Preparations